Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin

2-Hydroxypropyl-beta-cyclodextrin (HPBCD) is utilized in the formulation of pharmaceutical products and recently orphan designation was granted for the treatment of Niemann–Pick disease, type C. The exact mechanism of HPBCD action and side effects are not completely explained. We used fluorescently...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomolecules
Main Authors: Váradi, Judit, Hermenean, Anca, Gesztelyi, Rudolf, Jeney, Viktória, Balogh, Enikő, Majoros, László, Malanga, Milo, Fenyvesi, Éva, Szente, Lajos, Bácskay, Ildikó, Vecsernyés, Miklós, Fehér, Pálma, Ujhelyi, Zoltán, Vasvári, Gábor, Árvai, István, Rusznyák, Ágnes, Balta, Cornel, Herman, Hildegard, Fenyvesi, Ferenc
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6843445/
https://ncbi.nlm.nih.gov/pubmed/31546989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9100509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados